Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics

10x Genomics (TXG) reported $166.03 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 0.6%. EPS of -$0.13 for the same period compares to -$0.40 a year ago.The reported revenue represents a surprise of +0.01% over the Zacks Consensus Estimate of $166.01 million. With the consensus EPS estimate being -$0.19, the EPS surprise was +31.58%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wa ...